Luis E. Puig-Sanz
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.
Journal: JAMA dermatology
Published: May 15, 2026
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.
Journal: Dermatology and therapy
Published: March 08, 2026
Treatment-associated phenotype switching between psoriasis and atopic dermatitis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 11, 2026
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.
Journal: The Journal of dermatology
Published: February 04, 2026
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper.
Journal: The World Allergy Organization journal
Published: January 28, 2026
Effectiveness and Safety of 40 mg Modified-Release Doxycycline for the Treatment of Hidradenitis Suppurativa: A Single-Center Retrospective Observational Study.
Journal: Dermatology and therapy
Published: December 12, 2025
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
Journal: Acta dermato-venereologica
Published: November 04, 2025
Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.
Journal: Dermatology and therapy
Published: November 03, 2025
Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy.
Journal: Lancet (London, England)
Published: August 01, 2025
Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta‑Analysis".
Journal: Dermatology and therapy
Published: July 09, 2025
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis.
Journal: Annals of the rheumatic diseases
Published: July 04, 2025
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025
Last Updated: 09/26/2026